Company / Interest Expense
BIODESIX INC Interest Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$7.7M
FY2025
5-year range
$4.5M / $9.5M
FY2021-FY2025
Trend
-6.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $10M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025 with a 5-year CAGR of +0.3%.
Improved from $10M to $8M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -1.5%
- 5-Year CAGR
- +0.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.3%, indicating consistent growth.
- In FY2025, interest expense decreased 6.6% year-over-year.
- Peak interest expense was recorded in FY2023.
- Lowest interest expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.7M | -6.6% |
| FY2024 | $8.3M | -13.4% |
| FY2023 | $9.5M | +18.1% |
| FY2022 | $8.1M | +79.1% |
| FY2021 | $4.5M | -40.7% |
| FY2020 | $7.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026